Eye Disease and Blindness

Active Projects: 32

Project Investigator All Topics Start date End date
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
A point of care assay for chlamydia to assure prompt treatment in at risk minorities Julius Schachter, PhD Infectious Disease, Eye Disease and Blindness, Drug and Diagnostics Development
Fellowship - Award - 2016-2017 Pathogenesis and Treatment of Ebola-Associated Uveitis Rationale Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Characterization of TRPM1 isoforms and binding partners in ON bipolar cells Eye Disease and Blindness
Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma Yvonne Ou, MD Eye Disease and Blindness
Improving the prognostication and treatment of primary uveal melanoma Boris C. Bastian, MD, PhD Eye Disease and Blindness
Predictors of Response to Treatment in Fungal Keratitis Jennifer R. Rose-Nussbaumer, MD Eye Disease and Blindness
Village Integrated Eye Workers Trial Thomas M. Lietman, MD Eye Disease and Blindness
Village Integrated Eye Workers Trial Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Risk Reduction and Prevention
Sjögren International Collaborative Clinical Alliance (SICCA) Biorepository Caroline Shiboski, DDS, MPH, PhD Eye Disease and Blindness, Oral Health
Pedig-Master Agreement - Jaeb Center for Health Research, Inc. Alejandra G. De Alba Campomanes, MD, MPH Infectious Disease, Eye Disease and Blindness, Pediatrics
Pediatric Eye Disease Investigator Group-C02- Jaeb Center for Health Research, Inc. Alejandra G. De Alba Campomanes, MD, MPH Eye Disease and Blindness, Pediatrics
Pediatric Eye Disease Investigator Group- Jaeb Center for Health Research, Inc. Alejandra G. De Alba Campomanes, MD, MPH Eye Disease and Blindness, Pediatrics
Pediatric Eye Disease Investigator Group (PEDIG)-E02 task order under agreement A116115-Jaeb Center for Health Research Alejandra G. De Alba Campomanes, MD, MPH Noncommunicable and/or Chronic Disease, Eye Disease and Blindness, Pediatrics
The Genetics of Glaucoma in African Americans Neil J. Risch, PhD Eye Disease and Blindness, Genetics
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Eye Disease and Blindness, Pharmacology and Drug Treatment
Advanced Technology to Study Visual Function on a Cellular Scale Eye Disease and Blindness
P30 - Core Grant for Vision Research Matthew M. Lavail, PhD Eye Disease and Blindness
UCSF RPB Unrestricted Grant Application Stephen D. Mcleod, MD Infectious Disease, Eye Disease and Blindness
Macular Edema Treatment Trials Associated with MUST (META-MUST) Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development
International Clinical Research Fellowship Christopher C. Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) Jeremy D. Keenan, MD, MPH Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Development and Plasticity of the Visual System Michael P. Stryker, PhD Eye Disease and Blindness, Neurology and Mental Health
Intraocular Pressure Sensing Using Light David W. Sretavan, MD, PhD Eye Disease and Blindness
Macular Edema Treatment Trials Associated with MUST (META-MUST) Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development
Digital Detection of Infectious Eye Epidemics Thomas M. Lietman, MD Eye Disease and Blindness
Forecasting Trachoma Control Thomas M. Lietman, MD Eye Disease and Blindness, Epidemiology and Surveillance, Global Strategic Information
Phase 2a, Randomized, Placebo-controlled, Proof of Mechanism Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Subjects with Primary Sjogren's Syndrome Maria Dall'Era, MD Eye Disease and Blindness, Oral Health, Pharmacology and Drug Treatment
Diagnosis and treatment of infectious keratitis Stephen D. Mcleod, MD Infectious Disease, Eye Disease and Blindness
Neural Circuit Mechanisms of Experimental Amblyopia and Adult Recovery Michael P. Stryker, PhD Eye Disease and Blindness
Mortality Reduction After Oral Azithromycin Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Epidemiology and Surveillance

Active Projects: 56

Project Investigator All Topics Start date End date
Eliminating Trachoma with Repeat Mass Drug Treatment Eye Disease and Blindness
Predicting Resistance: Validating Mathematical Models Thomas M. Lietman, MD Eye Disease and Blindness, Epidemiology and Surveillance
Signal Processing in the Retina Eye Disease and Blindness
The Efficacy of Topically Applied Nepafenac in Prolonging Mydriasis in a Model of Phacoemusification Stephen D. Mcleod, MD Eye Disease and Blindness
RPB Unrestricted Grant Stephen D. Mcleod, MD Eye Disease and Blindness
Strategies for the Control and Elimination of Blinding Trachoma Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
What is the Appropriate Frequency and Duration of Mass Azithromycin Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Clinical Research Fellowship for Nisha Acharya Nisha Acharya, MD Eye Disease and Blindness
Multicenter Study in treating Macular Edema Nisha Acharya, MD Eye Disease and Blindness
Effect of Ranibizumab on Refractory Macular Edema in Uveitis Phase I/II Nisha Acharya, MD Eye Disease and Blindness
Eliminating Trachoma with Repeat Mass Drug Treatment Thomas M. Lietman, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Center for the Child with Visual Disabilities Stephen D. Mcleod, MD Eye Disease and Blindness, Pediatrics
2007 Horizon Grants Program - Retina Stephen D. Mcleod, MD Eye Disease and Blindness, Residencies, Fellowships, and Postdoctoral Training
The Steroids for Corneal Ulcers Trial Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment
Elimination of Infectious Trachoma from Ethiopia Using Repeated Mass Antibiotic Distributions Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
2008 Horizon Grants Program - F.I. Proctor Fellowship Stephen D. Mcleod, MD Eye Disease and Blindness, Residencies, Fellowships, and Postdoctoral Training
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Nisha Acharya, MD Eye Disease and Blindness
Predicting and Improving Critical Outcomes for Bacterial Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Using Stem Cells to Investigate Human Glaucoma Yvonne Ou, MD Eye Disease and Blindness
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Optimal Trachoma Control after Mass Antibiotic Distributions Jeremy D. Keenan, MD, MPH Eye Disease and Blindness
Mycotic Ulcer Treatment Trial (MUTT) Nisha Acharya, MD Infectious Disease, Eye Disease and Blindness
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis Nisha Acharya, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Research to Programs for Trachoma Elimination Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Iontophoresis Delivery of Dexamethason Phosphate for Non-Infectious, No-Necrotizing Anterior Scieritis, Phase I Dose-Varying Study Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Postnatal Serum IGF-1 Levels, Growth and Retinopathy of Prematurity in Latin-American Infants Alejandra G. De Alba Campomanes, MD, MPH Eye Disease and Blindness, Drug and Diagnostics Development, Pediatrics
Regulation of Herpes Simplex Type 1 Infection in Corneal Neurons Eye Disease and Blindness
F.I. Proctor Foundation Uveitis Fellowship training program Nisha Acharya, MD Eye Disease and Blindness, Training and Capacity Building
Studies of the Ocular Complications of AIDS (SOCA) HIV/AIDS, Eye Disease and Blindness
Assessment of cone structure and function with high resolution in eyes with retinal degeneration Eye Disease and Blindness
Postnatal Serum Insulin-Like Growth Factor 1 and Retinopathy of Prematurity in Latin-American Infants Alejandra G. De Alba Campomanes, MD, MPH Eye Disease and Blindness, Pediatrics
Development and Plasticity of the Visual System Michael P. Stryker, PhD Eye Disease and Blindness
UCSF RPB Unrestricted Grant Application Stephen D. Mcleod, MD Infectious Disease, Eye Disease and Blindness
Studies of Ocular Complications of AIDS (SOCA) Charles C. Kim, PhD HIV/AIDS, Eye Disease and Blindness
Tools for the Endgame: Accelerating the development and introduction of Dx to Support the London Declaration 2020 goals for Neglected Tropical Diseases (NTDs) Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Planning Grant for Parasitic Ulcer Treatment Trial Jeremy D. Keenan, MD, MPH Eye Disease and Blindness
Development of Neuroprotective Molecule for the Treatment of Atophic Age-Related Macular Degeneration Matthew M. Lavail, PhD Eye Disease and Blindness, Immunology
Nanoporous Films for Ocular Drug Delivery Tejal A. Desai, PhD Eye Disease and Blindness, Drug and Diagnostics Development
TANA II Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma Eye Disease and Blindness
Models of Retinal Degeneration Matthew M. Lavail, PhD Eye Disease and Blindness
CDA - Improving the Diagnosis and Treatment of Acanthamoeba Keratitis Jeremy D. Keenan, MD, MPH Eye Disease and Blindness
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Processing Uganda Swabs for Trachoma Alternative Indicators Study Julius Schachter, PhD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness
Multicenter Uveitis Steroid Treatment (MUST) Trial Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development
Models to study NMO disease mechanisms and new therapies. Alan S. Verkman, MD, PhD Eye Disease and Blindness
Detection of C. trachomatis on eye swabs Julius Schachter, PhD Eye Disease and Blindness, Drug and Diagnostics Development
The relationship between structure and function in inherited retinal disease Eye Disease and Blindness
Kearn Family Center for the Study of Retinal Degeneration Matthew M. Lavail, PhD Noncommunicable and/or Chronic Disease, Eye Disease and Blindness
Improving the quality of refractive eye care services provided in outreach camps and primary care centers in India: a mixed methods study Talita Rosa, MD Eye Disease and Blindness
Modeling Contact Investigation and Rapid Response Travis C. Porco, PhD, MPH Eye Disease and Blindness
Mycotic Ulcer Treatment Trial Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Postnatal Growth and Retinopathy of Prematurity (G-ROP) Studies Alejandra G. De Alba Campomanes, MD, MPH Eye Disease and Blindness, Pediatrics
Genetic and epigenetic contributions to Sjogrens syndrome Lindsey A. Criswell, MD, MPH Eye Disease and Blindness, Oral Health, Genetics
Immunologic determinants of age-related macular degeneration Peter W. Hunt, MD Eye Disease and Blindness, Immunology, Aging